Nutritional Sale Purchase Of Stock vs Capital Expenditures Analysis

NGS Stock

0.04 0.00 0.00%

Nutritional Growth financial indicator trend analysis is infinitely more than just investigating Nutritional Growth recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Nutritional Growth is a good investment. Please check the relationship between Nutritional Growth Sale Purchase Of Stock and its Capital Expenditures accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nutritional Growth Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Sale Purchase Of Stock vs Capital Expenditures

Sale Purchase Of Stock vs Capital Expenditures Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Nutritional Growth Sale Purchase Of Stock account and Capital Expenditures. At this time, the significance of the direction appears to have very week relationship.

The correlation between Nutritional Growth's Sale Purchase Of Stock and Capital Expenditures is 0.23. Overlapping area represents the amount of variation of Sale Purchase Of Stock that can explain the historical movement of Capital Expenditures in the same time period over historical financial statements of Nutritional Growth Solutions, assuming nothing else is changed. The correlation between historical values of Nutritional Growth's Sale Purchase Of Stock and Capital Expenditures is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Sale Purchase Of Stock of Nutritional Growth Solutions are associated (or correlated) with its Capital Expenditures. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Expenditures has no effect on the direction of Sale Purchase Of Stock i.e., Nutritional Growth's Sale Purchase Of Stock and Capital Expenditures go up and down completely randomly.

Correlation Coefficient

0.23

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Sale Purchase Of Stock

Capital Expenditures

Capital Expenditures are funds used by Nutritional Growth to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Nutritional Growth operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Most indicators from Nutritional Growth's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Nutritional Growth current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nutritional Growth Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Selling General Administrative is likely to drop to about 417.8 K in 2024. Issuance Of Capital Stock is likely to drop to about 661.2 K in 2024

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	146.6K	88.0K	4.1K	3.9K
Interest Income	47K	113K	249K	132.2K

Depreciation And Amortization Interest Income

Nutritional Growth fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Property Plant Equipment
Total Assets		-0.62	-0.31	-0.38	0.99	0.72	0.44	-0.41	0.03	-0.98	0.65	0.47	0.98	0.05	0.66	0.98	0.85	0.2	-0.46	0.26	0.19	-0.32	1.0	-0.75	-0.45	-0.44
Short Long Term Debt Total	-0.62		0.49	0.69	-0.7	-0.9	0.27	0.12	-0.06	0.66	-0.75	-0.19	-0.62	0.4	-0.66	-0.62	-0.63	0.46	0.31	0.14	-0.04	0.71	-0.63	0.96	0.64	0.32
Other Current Liab	-0.31	0.49		0.8	-0.41	-0.38	0.47	0.73	-0.23	0.44	-0.88	-0.54	-0.43	0.87	-0.69	-0.43	-0.76	0.58	0.72	0.42	0.54	0.83	-0.34	0.36	0.91	0.77
Total Current Liabilities	-0.38	0.69	0.8		-0.51	-0.53	0.33	0.4	0.08	0.53	-0.9	-0.09	-0.51	0.57	-0.87	-0.51	-0.66	0.45	0.8	0.23	0.1	0.99	-0.4	0.63	0.96	0.57
Total Stockholder Equity	0.99	-0.7	-0.41	-0.51		0.78	0.33	-0.43	0.01	-0.99	0.75	0.44	0.99	-0.06	0.76	0.99	0.89	0.1	-0.54	0.2	0.17	-0.45	0.99	-0.82	-0.57	-0.48
Other Liab	0.72	-0.9	-0.38	-0.53	0.78		-0.11	-0.24	-0.14	-0.75	0.71	0.13	0.72	-0.22	0.69	0.72	0.66	-0.17	-0.33	0.13	0.13	-0.52	0.73	-0.95	-0.5	-0.33
Net Tangible Assets	0.44	0.27	0.47	0.33	0.33	-0.11		0.21	0.03	-0.37	-0.23	0.06	0.41	0.71	0.03	0.41	0.04	0.65	-0.09	0.32	0.69	0.42	0.41	0.07	0.33	0.34
Property Plant And Equipment Net	-0.41	0.12	0.73	0.4	-0.43	-0.24	0.21		0.14	0.46	-0.64	-0.5	-0.47	0.44	-0.48	-0.47	-0.73	-0.07	0.57	-0.19	0.63	0.38	-0.42	0.16	0.61	0.94
Current Deferred Revenue	0.03	-0.06	-0.23	0.08	0.01	-0.14	0.03	0.14		0.0	0.01	0.74	0.0	-0.47	-0.17	0.0	0.14	-0.62	0.11	-0.83	-0.17	-0.02	0.04	0.13	-0.02	0.15
Net Debt	-0.98	0.66	0.44	0.53	-0.99	-0.75	-0.37	0.46	0.0		-0.76	-0.44	-1.0	0.06	-0.8	-1.0	-0.89	-0.11	0.62	-0.19	-0.2	0.47	-0.98	0.78	0.59	0.49
Retained Earnings	0.65	-0.75	-0.88	-0.9	0.75	0.71	-0.23	-0.64	0.01	-0.76		0.39	0.75	-0.6	0.92	0.75	0.9	-0.36	-0.8	-0.15	-0.2	-0.89	0.67	-0.73	-0.95	-0.73
Accounts Payable	0.47	-0.19	-0.54	-0.09	0.44	0.13	0.06	-0.5	0.74	-0.44	0.39		0.45	-0.51	0.15	0.45	0.65	-0.32	-0.19	-0.43	-0.45	-0.14	0.49	-0.1	-0.32	-0.45
Cash	0.98	-0.62	-0.43	-0.51	0.99	0.72	0.41	-0.47	0.0	-1.0	0.75	0.45		-0.04	0.79	1.0	0.89	0.14	-0.63	0.2	0.2	-0.45	0.98	-0.74	-0.58	-0.48
Non Current Assets Total	0.05	0.4	0.87	0.57	-0.06	-0.22	0.71	0.44	-0.47	0.06	-0.6	-0.51	-0.04		-0.34	-0.04	-0.44	0.86	0.36	0.71	0.64	0.67	0.01	0.17	0.66	0.5
Other Assets	0.66	-0.66	-0.69	-0.87	0.76	0.69	0.03	-0.48	-0.17	-0.8	0.92	0.15	0.79	-0.34		0.79	0.8	-0.15	-0.91	0.0	0.16	-0.82	0.68	-0.7	-0.85	-0.52
Cash And Short Term Investments	0.98	-0.62	-0.43	-0.51	0.99	0.72	0.41	-0.47	0.0	-1.0	0.75	0.45	1.0	-0.04	0.79		0.89	0.14	-0.63	0.2	0.2	-0.45	0.98	-0.74	-0.58	-0.48
Net Receivables	0.85	-0.63	-0.76	-0.66	0.89	0.66	0.04	-0.73	0.14	-0.89	0.9	0.65	0.89	-0.44	0.8	0.89		-0.14	-0.7	-0.02	-0.22	-0.63	0.86	-0.66	-0.79	-0.77
Common Stock Shares Outstanding	0.2	0.46	0.58	0.45	0.1	-0.17	0.65	-0.07	-0.62	-0.11	-0.36	-0.32	0.14	0.86	-0.15	0.14	-0.14		0.09	0.89	0.34	0.57	0.17	0.18	0.44	0.05
Inventory	-0.46	0.31	0.72	0.8	-0.54	-0.33	-0.09	0.57	0.11	0.62	-0.8	-0.19	-0.63	0.36	-0.91	-0.63	-0.7	0.09		0.09	-0.06	0.75	-0.48	0.35	0.82	0.54
Other Current Assets	0.26	0.14	0.42	0.23	0.2	0.13	0.32	-0.19	-0.83	-0.19	-0.15	-0.43	0.2	0.71	0.0	0.2	-0.02	0.89	0.09		0.17	0.34	0.23	-0.12	0.24	-0.16
Other Stockholder Equity	0.19	-0.04	0.54	0.1	0.17	0.13	0.69	0.63	-0.17	-0.2	-0.2	-0.45	0.2	0.64	0.16	0.2	-0.22	0.34	-0.06	0.17		0.16	0.17	-0.18	0.29	0.68
Total Liab	-0.32	0.71	0.83	0.99	-0.45	-0.52	0.42	0.38	-0.02	0.47	-0.89	-0.14	-0.45	0.67	-0.82	-0.45	-0.63	0.57	0.75	0.34	0.16		-0.34	0.61	0.96	0.55
Total Current Assets	1.0	-0.63	-0.34	-0.4	0.99	0.73	0.41	-0.42	0.04	-0.98	0.67	0.49	0.98	0.01	0.68	0.98	0.86	0.17	-0.48	0.23	0.17	-0.34		-0.76	-0.48	-0.45
Short Term Debt	-0.75	0.96	0.36	0.63	-0.82	-0.95	0.07	0.16	0.13	0.78	-0.73	-0.1	-0.74	0.17	-0.7	-0.74	-0.66	0.18	0.35	-0.12	-0.18	0.61	-0.76		0.57	0.33
Common Stock	-0.45	0.64	0.91	0.96	-0.57	-0.5	0.33	0.61	-0.02	0.59	-0.95	-0.32	-0.58	0.66	-0.85	-0.58	-0.79	0.44	0.82	0.24	0.29	0.96	-0.48	0.57		0.74
Property Plant Equipment	-0.44	0.32	0.77	0.57	-0.48	-0.33	0.34	0.94	0.15	0.49	-0.73	-0.45	-0.48	0.5	-0.52	-0.48	-0.77	0.05	0.54	-0.16	0.68	0.55	-0.45	0.33	0.74

Click cells to compare fundamentals

Nutritional Growth Account Relationship Matchups

Nutritional Growth fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.2M	5.2M	3.4M	3.0M	936K	889.2K
Short Long Term Debt Total	56.9K	191.2K	52.9K	37K	362K	380.1K
Other Current Liab	230.5K	579K	602.7K	674.0K	499.0K	496.6K
Total Current Liabilities	337.2K	765K	600.2K	954.0K	1.1M	777.8K
Total Stockholder Equity	872.0K	4.3M	2.8M	2.1M	(177K)	(168.2K)
Net Tangible Assets	613K	4.2M	3.8M	2.0M	2.3M	2.8M
Property Plant And Equipment Net	25.6K	13K	58.0K	43K	27K	33.7K
Net Debt	(768.2K)	(4.5M)	(2.9M)	(1.5M)	190K	199.5K
Retained Earnings	237.6K	(4.2M)	(6.5M)	(13.2M)	(16.1M)	(15.3M)
Accounts Payable	49.8K	186K	154.4K	243K	252K	218.0K
Cash	825.1K	4.6M	3.0M	1.5M	172K	163.4K
Non Current Assets Total	25.6K	163.0K	101.5K	83.0K	47K	80.1K
Cash And Short Term Investments	825.1K	4.6M	3.0M	1.5M	172K	163.4K
Net Receivables	93.9K	278K	103.7K	88K	18K	17.1K
Liabilities And Stockholders Equity	1.2M	5.2M	3.4M	3.0M	936.0K	889.2K
Inventory	193.5K	145K	229.0K	1.3M	681K	481.8K
Other Current Assets	71.1K	200.9K	(1K)	60K	18K	17.1K
Total Liab	337.2K	894K	627.0K	954.0K	1.1M	808.4K
Total Current Assets	1.2M	5.1M	3.3M	2.9M	889K	844.6K
Accumulated Other Comprehensive Income	631.6K	735K	1.3M	1.9M	73.3K	69.6K
Short Term Debt	56.9K	62.2K	36K	37K	351K	368.6K
Common Stock	2.8K	7.8M	8.0M	13.4M	15.9M	8.3M
Property Plant Equipment	18K	13K	80K	43K	49.5K	36.5K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Nutritional Stock Analysis

When running Nutritional Growth's price analysis, check to measure Nutritional Growth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutritional Growth is operating at the current time. Most of Nutritional Growth's value examination focuses on studying past and present price action to predict the probability of Nutritional Growth's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutritional Growth's price. Additionally, you may evaluate how the addition of Nutritional Growth to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC